Ariston Services Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$286K Hold
10,040
– – 0.16% 52
2026
Q2
$242K Buy
+10,040
New +$263K 0.13% 66
2026
Q1
– Sell
-10,040
Closed -$267K – 52
2025
Q4
$250K Hold
10,040
– – 0.15% 62
2025
Q3
$256K Hold
10,040
– – 0.15% 62
2025
Q2
$243K Hold
10,040
– – 0.17% 62
2025
Q1
$254K Sell
10,040
-115
-1% -$3.01K 0.21% 57
2024
Q4
$269K Buy
+10,155
New +$275K 0.23% 51

Other funds holding PFE

Ariston Services Group's PFE Position: Q3 2026 in Review

Ariston Services Group held its Pfizer (PFE) position steady in Q3 2026 at 10,040 shares worth $286K. The position accounts for 0.16% of the portfolio, ranked #52.

Ariston Services Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. 718 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Ariston Services Group held 10,040 shares of Pfizer worth $286K as of Q3 2026.
  • Ariston Services Group left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.16% of Ariston Services Group's portfolio in Q3 2026, its #52 holding.
  • Ariston Services Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • 718 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Ariston Services Group's 13F filing for Q3 2026, filed 16 Oct 2026.